Language: BG BG
← Back to results
Not yet recruiting Not applicable NCT07115420

Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent

No applicable phase (e.g. observational)
Conditions: Malignant Biliary Obstruction Advanced Pancreatic Cancer and Cholangiocarcinoma Inoperable Malignant Biliary Obstruction Lumen Apposing Metal Stents

Sponsor: Waikato Hospital

trial.available_in: БГ
Overview
This study looks at the best way to treat bile duct blockage in people with advanced cancer that cannot be removed by surgery. A blocked bile duct can cause serious symptoms like yellowing of the skin (jaundice), infection, and pain. A common procedure called ERCP sometimes doesn't work in these patients. A newer method called EUS-guided choledochoduodenostomy (EUS-CDS) uses internal ultrasound to place a special metal tube (called a LAMS) to allow bile to drain. However, over time this stent can still become blocked. To reduce this risk, doctors can place a second stent inside the first. This study is comparing two types of these second stents: * A plastic stent (double pigtail stent or DPS) * A metal stent (fully covered self-expanding metal stent or FCSEMS) The study will include patients at Waikato Hospital. After the first stent is placed, they will be randomly assigned to receive either a DPS or FCSEMS. Patients will be followed for 6 months to see how well the stents work. The aim is to find out which approach keeps the bile duct open longer and reduces the need for further procedures or hospitalisation, helping improve care and comfort for people with advanced cancer
Who can participate
Inclusion Criteria: * Age ≥18 years. * Radiologically or histologically proven malignant distal bile duct obstruction with unresectable or metastatic disease, including those who have already failed ERCP * Indication for biliary drainage with presence of obstructive jaundice biochemically and dilated biliary system on imaging. * Informed consent provided. * Common bile duct (CBD) size of at least 12mm on EUS imaging Exclusion Criteria: * Previous biliary stenting or surgery precluding EUS-CDS. * Inability to provide informed consent. * Pregnancy. * Significant coagulopathy that is not correctable. * Futility of intervention e.g. pre-terminal patients
Locations 1
New Zealand (1)
Waikato Hospital, Te Whatu Ora Health New Zealand Waikato
Hamilton
Frank Weilert, BSc, MBBCh, FRACP and FASGE
Technical details
Status
Not yet recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
01.09.2025
Completion date
01.03.2028
Registry ID
NCT07115420
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.